Taiwan · Delayed Price · Currency is TWD Chunghwa Chemical Synthesis & Biotech Company Description
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in Taiwan and the United States.
It offers API products, which include immunosuppressant, oncology, anti-virus, immunomodulating agents, and other products, as well as peptide drugs.
The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services.
The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is based in New Taipei City, Taiwan.
| Country | Taiwan |
| Founded | 1964 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 198 |
| CEO | Qing-Peng Wei |
Contact Details
Address: No. 1 Tung-Hsing Street New Taipei City, 23850 Taiwan | |
| Phone | 886 2 8684 3318 |
| Website | ccsb.com.tw |
Stock Details
| Ticker Symbol | 1762 |
| Exchange | Taiwan Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0001762003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Qing-Peng Wei | General Manager |
| Kuan-Chieh Wang | Manager of Finance Department and Head of Corporate Governance |
| Guanjie Wang | Accounting Supervisor |
| Jun-Jie Liao | Manager of Human Resource Office |
| Chao-Sheng Hong | Chief Auditor |